Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 22 (3), 220-8

Most Important Chronic Complications of Arteriovenous Fistulas for Hemodialysis


Most Important Chronic Complications of Arteriovenous Fistulas for Hemodialysis

Radojica Stolic. Med Princ Pract.


The aim of this review was to highlight the most important complications of arteriovenous fistulas (AVFs) for hemodialysis (HD). The quality of vascular access for HD should be suitable for repeated puncture and allow a high blood flow rate for high-efficiency dialysis with minimal complications. The dialysis staff must be well versed in manipulation of the AVF, and there should be a minimal need for corrective interventions. Construction of an AVF creates conditions for increasing the flow of blood through the venous system. Fulfillment of these conditions reduces the risk of turbulence and endothelium injury, which, in turn, minimizes the potential for stenosis. An AVF is closest to the ideal model of vascular access. The most important complications of fistulae for HD are lymphedema, infection, aneurysm, stenosis, congestive heart failure, steal syndrome, ischemic neuropathy and thrombosis. In HD patients, the most common cause of vascular access failure is neointimal hyperplasia. It is important to gain information about early clinical symptoms of AVF dysfunction in order to prevent and adequately treat potential complications.

Similar articles

See all similar articles

Cited by 16 articles

See all "Cited by" articles


    1. Quinton WE, Dillard DH, Scribner BH. Cannulation of blood vessels for prolonged hemodialysis. Trans Am Soc Artif Intern Organs. 1960;6:104–113. - PubMed
    1. Konner K. History of vascular access for haemodialysis. Nephrol Dial Transplant. 2005;20:2629–2635. - PubMed
    1. Allon M. Current management of vascular access. Clin J Am Soc Nephrol. 2007;2:786–800. - PubMed
    1. Schon D, Blume WS, Niebauer K, Hollenbeak CS, de Lissovoy G. Increasing the use of arteriovenous fistula in hemodialysis: economic benefits and economic barriers. Clin J Am Soc Nephrol. 2007;2:268–276. - PubMed
    1. Metcalfe W, Khan IH, Prescott GJ, Simpson K, Macleod AM, on behalf of the Scottish Renal Registry hospitalization in the first year of renal replacement therapy for end-stage renal disease. QJM. 2003;96:899–909. - PubMed

Publication types

MeSH terms